FIL Ltd acquired a new stake in shares of GoHealth, Inc. (NASDAQ:GOCO) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 531,488 shares of the company’s stock, valued at approximately $7,260,000.
Other hedge funds also recently added to or reduced their stakes in the company. Cubist Systematic Strategies LLC bought a new position in GoHealth during the third quarter valued at approximately $41,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of GoHealth during the 4th quarter worth approximately $87,000. Point72 Europe London LLP bought a new position in shares of GoHealth during the 3rd quarter valued at approximately $130,000. Arizona State Retirement System purchased a new position in shares of GoHealth in the fourth quarter valued at $167,000. Finally, Sei Investments Co. bought a new stake in GoHealth in the third quarter worth $165,000. 26.55% of the stock is currently owned by hedge funds and other institutional investors.
In other news, CFO Travis J. Matthiesen sold 146,000 shares of the firm’s stock in a transaction dated Monday, January 11th. The stock was sold at an average price of $14.98, for a total value of $2,187,080.00. Following the completion of the transaction, the chief financial officer now directly owns 146,000 shares in the company, valued at $2,187,080. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Shane E. Cruz sold 113,171 shares of GoHealth stock in a transaction dated Tuesday, February 9th. The stock was sold at an average price of $15.02, for a total value of $1,699,828.42. Following the sale, the chief operating officer now directly owns 113,171 shares of the company’s stock, valued at approximately $1,699,828.42. The disclosure for this sale can be found here. Insiders sold a total of 346,000 shares of company stock valued at $5,162,580 in the last three months.
A number of brokerages have commented on GOCO. Raymond James reissued a “buy” rating on shares of GoHealth in a research note on Thursday, November 12th. Evercore ISI lowered their target price on GoHealth from $27.00 to $25.00 and set an “outperform” rating for the company in a report on Thursday, November 12th. Zacks Investment Research lowered GoHealth from a “hold” rating to a “sell” rating in a research note on Tuesday, January 12th. Credit Suisse Group lowered their price objective on shares of GoHealth from $25.00 to $21.00 and set an “outperform” rating for the company in a research note on Monday, November 16th. Finally, Morgan Stanley cut their target price on shares of GoHealth from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 12th. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $20.30.
As a leading health insurance marketplace, GoHealth's mission is to improve access to healthcare in America. Enrolling in a health insurance plan can be confusing for customers, and the seemingly small differences between plans can lead to significant out-of-pocket costs or lack of access to critical medicines and even providers.
Want to see what other hedge funds are holding GOCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GoHealth, Inc. (NASDAQ:GOCO).
Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.